Allworth Financial LP Nevro Corp Transaction History

Allworth Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$7.96 - $13.59 $1,178 - $2,011	148 New	148 $1,000
Q3 2023 Oct 31, 2023	BUY	$18.22 - $25.85 $2,295 - $3,257	126 Added 630.0%	146 $2,000
Q2 2023 Jul 18, 2023	BUY	$22.62 - $39.32 $452 - $786	20 New	20 $0
Q3 2022 Oct 18, 2022	BUY	$40.66 - $53.03 $1,829 - $2,386	45 Added 1125.0%	49 $2,000
Q2 2022 Jul 13, 2022	BUY	$40.85 - $77.67 $163 - $310	4 New	4 $0

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

Stay updated on Allworth Financial LP with notifications on news.